Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

HIV Infection

Free Subscription Articles published in AIDS Res Hum Retroviruses Retrieve available abstracts of 216 articles: HTML format

Single Articles

November 2023
1. LI T, Qian K, Han J, Liu Y, et al
   Higher expression of HERV-K was observed in peripherial B Lymphocytes of Leukemia and Lymphoma Patients.
   AIDS Res Hum Retroviruses. 2023 Nov 27. doi: 10.1089/AID.2023.0037.
   PubMed     Abstract available
   
   
   
2. DONG S, Lu X, Wang Y, An N, et al
   Near-full-length genome analysis of a HIV-1 CRF01_AE/B recombinant strain among men who have sex with men in Chengde City, China.
   AIDS Res Hum Retroviruses. 2023 Nov 19. doi: 10.1089/AID.2023.0110.
   PubMed     Abstract available
   
   
   October 2023
3. ZHANG L, Cai M, Su B, Zhang Y, et al
   Mitochondrial metabolism in alveolar macrophages of patients infected with HIV, tuberculosis (TB) and HIV/TB.
   AIDS Res Hum Retroviruses. 2023 Oct 26. doi: 10.1089/AID.2023.0064.
   PubMed     Abstract available
   
   
   
4. LAPER S, Hileman CO, Block G, Erlandson KM, et al
   Perceived risks and benefits and frequency of cannabis use among people with HIV in different legal environments.
   AIDS Res Hum Retroviruses. 2023 Oct 12. doi: 10.1089/AID.2022.0144.
   PubMed     Abstract available
   
   
   
5. COHEN MAA, Bourgeois JA
   HIV Psychiatry - the Missing Link to HIV Prevention and Comprehensive Care.
   AIDS Res Hum Retroviruses. 2023 Oct 4. doi: 10.1089/AID.2022.0184.
   PubMed     Abstract available
   
   
   
6. VAN PAASSEN P, Dijkstra M, Peay H, Rokx C, et al
   Perceptions of rapid ART initiation among participants of the Netherlands Cohort Study on Acute HIV infection.
   AIDS Res Hum Retroviruses. 2023 Oct 4. doi: 10.1089/AID.2022.0169.
   PubMed     Abstract available
   
   
   September 2023
7. CASTELLI A, Lanzafame M, Morra M, Bertoldi M, et al
   Acceptability of switching to long acting cabotegravir and rilpivirine among people living with HIV on dolutegravir/rilpivirine combination: A single-center experience.
   AIDS Res Hum Retroviruses. 2023 Sep 30. doi: 10.1089/AID.2023.0070.
   PubMed     Abstract available
   
   
   
8. FISHER S, Jao J, Yee LM, Serghides L, et al
   Association of fatty acid signatures with HIV viremia in pregnancy.
   AIDS Res Hum Retroviruses. 2023 Sep 29. doi: 10.1089/AID.2023.0040.
   PubMed     Abstract available
   
   
   
9. SILVA NMD, Leite NPM, Carvalho AE, Almeida VD, et al
   THE ROLE OF EXTRACELLULAR TRAPS IN HIV INFECTION.
   AIDS Res Hum Retroviruses. 2023 Sep 29. doi: 10.1089/AID.2022.0178.
   PubMed     Abstract available
   
   
   
10. SECHER S, Hentzien M, Cuzin L, Jacomet C, et al
    No association between HLA -B*57:01 and prevalence and/or outcome of progressive multifocal leukoencephalopathy in a French Nationwide HIV cohort.
    AIDS Res Hum Retroviruses. 2023 Sep 27. doi: 10.1089/AID.2023.0050.
    PubMed     Abstract available
    
    
    
11. MALCIOLU AM, Costescu C, Popescu C, Florescu S, et al
    Mpox-related ophthalmic disease. A rare case report.
    AIDS Res Hum Retroviruses. 2023 Sep 27. doi: 10.1089/AID.2023.0010.
    PubMed     Abstract available
    
    
    
12. SCHUETTFORT G, Roether C, Berger A, Fokas E, et al
    Differences in the course of CD4 and CD8 cells after chemoradiotherapy in PLWH with anal cancer.
    AIDS Res Hum Retroviruses. 2023 Sep 27. doi: 10.1089/AID.2023.0003.
    PubMed     Abstract available
    
    
    
13. MAVARANI L, Reinsch N, Albayrak-Rena S, Potthoff A, et al
    The association of HIV-specific risk factors with cardiovascular events in addition to traditional risk factors in people living with HIV.
    AIDS Res Hum Retroviruses. 2023 Sep 7. doi: 10.1089/AID.2023.0055.
    PubMed     Abstract available
    
    
    
14. COLLURA R, O'Grady T, Swain CA, Patterson W, et al
    Molecular HIV Clustering Among Individuals with Mpox and HIV Co-morbidity in New York State, Excluding New York City.
    AIDS Res Hum Retroviruses. 2023 Sep 2. doi: 10.1089/AID.2023.0009.
    PubMed     Abstract available
    
    
    
15. CHENG P, He BC, Liu J, Wang J, et al
    Using the molecular transmission networks to analysis the epidemic characteristics of HIV-1 CRF08_BC in Kunming,Yunnan.
    AIDS Res Hum Retroviruses. 2023 Sep 2. doi: 10.1089/AID.2023.0060.
    PubMed     Abstract available
    
    
    August 2023
16. IROEZINDU M, Crowell T, Ogoina D, Yinka-Ogunleye A, et al
    Human Mpox in People Living with HIV: Epidemiologic and Clinical Perspectives from Nigeria.
    AIDS Res Hum Retroviruses. 2023 Aug 30. doi: 10.1089/AID.2023.0034.
    PubMed     Abstract available
    
    
    
17. LANZAFAME M, Lattuada E, Luise D, Delama A, et al
    SHORT CYCLE, INTERMITTENT THERAPY: A VALUABLE OPTION IN SELECTED, VIROLOGICALLY SUPPRESSED PEOPLE LIVING WITH HIV.
    AIDS Res Hum Retroviruses. 2023 Aug 8. doi: 10.1089/AID.2022.0168.
    PubMed     Abstract available
    
    
    
18. MARQUIS KA, Merenstein C, Bushman F
    2-hydroxyisovalerate is produced during bacterial vaginosis and boosts HIV infection in resting T cells.
    AIDS Res Hum Retroviruses. 2023 Aug 7. doi: 10.1089/AID.2022.0171.
    PubMed     Abstract available
    
    
    
19. MALLIPEDDI VP, Levy M, Byrne M, Monroe A, et al
    Evaluation of New Hypertension Guidelines on the Prevalence and Control of Hypertension in a Clinical HIV Cohort: A Community-Based Study.
    AIDS Res Hum Retroviruses. 2023 Aug 1. doi: 10.1089/AID.2022.0063.
    PubMed     Abstract available
    
    
    July 2023
20. DI CARLO D, Falasca F, Mazzuti L, Guerrizio G, et al
    MicroRNA Expression Levels in Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus Type 1 Positive Individuals and Relationship with Different Levels of Viral Suppression.
    AIDS Res Hum Retroviruses. 2023 Jul 31. doi: 10.1089/aid.2022.0165.
    PubMed     Abstract available
    
    
    
21. WOHLFEILER MB, Weber RP, Brunet L, Siddiqui J, et al
    Definition, Burden, and Predictors of HIV-Associated Wasting and Low Weight in the OPERA((R)) Cohort.
    AIDS Res Hum Retroviruses. 2023 Jul 25. doi: 10.1089/AID.2023.0048.
    PubMed     Abstract available
    
    
    
22. QUINA M, Ramos D, Silva C, Padua E, et al
    Diversity of Human T-Lymphotropic Virus type 1 Cosmopolitan subtype (HTLV-1a) circulating in infected-residents in Portugal.
    AIDS Res Hum Retroviruses. 2023 Jul 18. doi: 10.1089/AID.2023.0026.
    PubMed     Abstract available
    
    
    
23. MARTINEZ DE VICTORIA-CARAZO J, Garcia-Ceberino PM, de Salazar-Gonzalez A, Faro-Miguez N, et al
    MONKEYPOX VIRUS (MPXV) INFECTION AND SEXUALLY TRANSMITTED INFECTIONS (STIs): A CROSS-SECTIONAL STUDY FROM A SECONDARY HOSPITAL IN THE MAY-SEPTEMBER 2022 INTERNATIONAL OUTBREAK.
    AIDS Res Hum Retroviruses. 2023 Jul 14. doi: 10.1089/AID.2023.0016.
    PubMed     Abstract available
    
    
    
24. COSSARINI F, Aberg J, Chen BK, Mehandru S, et al
    Viral persistence in the Gut-Associated Lymphoid Tissue and barriers to HIV cure.
    AIDS Res Hum Retroviruses. 2023 Jul 14. doi: 10.1089/AID.2022.0180.
    PubMed     Abstract available
    
    
    
25. POUDEL-TANDUKAR K, Bertone-Johnson ER, Poudel KC
    Serum selenium and inflammation in individuals with Human Immunodeficiency Virus Infection.
    AIDS Res Hum Retroviruses. 2023 Jul 10. doi: 10.1089/AID.2023.0012.
    PubMed     Abstract available
    
    
    
26. ESSAJEE N, Oddo Moise H, Hagensee M, Lillis R, et al
    Characteristics of Mpox Infections in Louisiana in the 2022 Outbreak.
    AIDS Res Hum Retroviruses. 2023 Jul 10. doi: 10.1089/AID.2023.0011.
    PubMed     Abstract available
    
    
    
27. TEIXEIRA SV, Prates GS, Fonseca LAM, Casseb J, et al
    Can persistent infections with hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and human T- lymphotropic virus (HTLV) be eradicated?
    AIDS Res Hum Retroviruses. 2023 Jul 6. doi: 10.1089/AID.2022.0116.
    PubMed     Abstract available
    
    
    
28. GBADAMOSI SO, Boyce G, Trepka MJ, Edwards RJ, et al
    The Burden of Pretreatment HIV Drug Resistance in Trinidad and Tobago.
    AIDS Res Hum Retroviruses. 2023 Jul 6. doi: 10.1089/AID.2022.0155.
    PubMed     Abstract available
    
    
    
29. DUBE K
    RFS Proudly Announces the 2022 Award Recipient for AIDS Research and Human Retroviruses.
    AIDS Res Hum Retroviruses. 2023;39:317.
    PubMed    
    
    
    June 2023
30. RAMIREZ HC, Monroe A, O'Connor L, Byrne M, et al
    Examining the Association Between a Modified Quan-Charlson Comorbidity Index (QCCI) and HIV Viral Suppression: A Cross-Sectional Analysis of DC Cohort Participants.
    AIDS Res Hum Retroviruses. 2023 Jun 30. doi: 10.1089/AID.2022.0186.
    PubMed     Abstract available
    
    
    
31. PRUDDEN HJ, Tatoud R, Janes H, Wallace S, et al
    Perspectives on Design Approaches for HIV Prevention Efficacy Trials.
    AIDS Res Hum Retroviruses. 2023 Jun 30. doi: 10.1089/AID.2022.0150.
    PubMed     Abstract available
    
    
    
32. MAZONSON P, Berko J, Lowman E, Gilliam B, et al
    Number of Sexual Partners and Patient-Reported Outcomes Among Men Age 50+ with HIV.
    AIDS Res Hum Retroviruses. 2023 Jun 28. doi: 10.1089/aid.2023.0004.
    PubMed     Abstract available
    
    
    
33. LOMBARDI F, Bruzzesi E, Bouba Y, Di Carlo D, et al
    Factors associated with low-level viremia in people living with HIV in the Italian ARCA cohort: a case-control study.
    AIDS Res Hum Retroviruses. 2023 Jun 22. doi: 10.1089/AID.2023.0015.
    PubMed     Abstract available
    
    
    
34. DU J, Lin Y, Liang H, Li J, et al
    Hyper-glycosylated N-linked site 339 of gp120 appears to be unique and may contribute to CRF01_AE transmission among men who have sex with men in China and Thailand.
    AIDS Res Hum Retroviruses. 2023 Jun 19. doi: 10.1089/AID.2022.0176.
    PubMed     Abstract available
    
    
    
35. LEE EH, Lee JA, Kim CH, Lee KH, et al
    Pentraxin 3 as an immune recovery marker in HIV infection after combination antiretroviral therapy.
    AIDS Res Hum Retroviruses. 2023 Jun 19. doi: 10.1089/AID.2023.0002.
    PubMed     Abstract available
    
    
    
36. JADHAV SD, Nema V
    Association of viral and host genetic architecture with the status of neurocognitive disorder in HIV-infected individuals.
    AIDS Res Hum Retroviruses. 2023 Jun 19. doi: 10.1089/AID.2022.0099.
    PubMed     Abstract available
    
    
    
37. LIU M, Chen H, Li J, Cai W, et al
    Near Full-Length Genomic Characterization of Two Novel HIV Type 1 Second-generation Recombinant Form (CRF01_AE/CRF07_BC) from Guangxi, China.
    AIDS Res Hum Retroviruses. 2023 Jun 19. doi: 10.1089/AID.2023.0043.
    PubMed     Abstract available
    
    
    
38. CAI H, Du J, Miaomiao S, Meng J, et al
    Genomic Characterization of a Novel HIV-1 Second-Generation Recombinant (CRF01_AE/CRF07_BC) Identified from an MSM Patient in Hebei, China.
    AIDS Res Hum Retroviruses. 2023 Jun 19. doi: 10.1089/AID.2023.0035.
    PubMed     Abstract available
    
    
    
39. GODWE C, Vidal N, Muwonga J, Butel C, et al
    Structural features and genetic diversity in Gag gene of rare HIV-1 subtypes from the Democratic Republic of Congo.
    AIDS Res Hum Retroviruses. 2023 Jun 19. doi: 10.1089/AID.2022.0154.
    PubMed     Abstract available
    
    
    
40. LU X, Ma L, Xu J, Li Y, et al
    Changes of viral load, drug resistance, and CD4 cell count in HIV-1-infected patients receiving antiretroviral therapy in Hebei Province, China, 2003 - 2019.
    AIDS Res Hum Retroviruses. 2023 Jun 19. doi: 10.1089/AID.2023.0006.
    PubMed     Abstract available
    
    
    
41. CALZA L, Colangeli V, Legnani G, Cretella S, et al
    EFFICACY AND SAFETY OF SWITCHING TO DOLUTEGRAVIR/LAMIVUDINE IN VIROLOGICALLY SUPPRESSED PEOPLE LIVING WITH HIV-1 AGED OVER 65 YEARS.
    AIDS Res Hum Retroviruses. 2023 Jun 19. doi: 10.1089/AID.2023.0046.
    PubMed     Abstract available
    
    
    
42. OLIVEIRA RC, Souza JSM, Alcantara LC, Guimaraes ML, et al
    Molecular and phylogenetic analysis of HIV-1 subtype C in Bahia state, northeastern Brazil.
    AIDS Res Hum Retroviruses. 2023 Jun 14. doi: 10.1089/AID.2023.0038.
    PubMed     Abstract available
    
    
    
43. MA Y, Wan Z, Zhang M, Zhang C, et al
    Genomic characteristics of the new HIV-1 CRF07_BC K(28)E(32) variant.
    AIDS Res Hum Retroviruses. 2023 Jun 14. doi: 10.1089/AID.2022.0182.
    PubMed     Abstract available
    
    
    
44. ACIN GARCES P, Luque S, Subirana I, Vila J, et al
    Development and validation of a Risk Score for Predicting Non-Adherence to Antiretroviral Therapy.
    AIDS Res Hum Retroviruses. 2023 Jun 9. doi: 10.1089/AID.2022.0147.
    PubMed     Abstract available
    
    
    
45. AURPIBUL L, Parklak W, Taejaroenkul S, Rerkasem A, et al
    Chronic kidney disease and accelerated decline of renal function in older adults with HIV in northern Thailand.
    AIDS Res Hum Retroviruses. 2023 Jun 5. doi: 10.1089/AID.2023.0032.
    PubMed     Abstract available
    
    
    
46. PATEL Y, Doshi A, Levesque A, Lindor S, et al
    Weight Gain in People with HIV: The role of demographics, antiretroviral therapy, and lifestyle factors on weight.
    AIDS Res Hum Retroviruses. 2023 Jun 5. doi: 10.1089/AID.2023.0008.
    PubMed     Abstract available
    
    
    
47. ABDO M, Kunisaki KM, Morris A, Stosor V, et al
    Pulmonary Function and Quality of Life in Aging Men with and without HIV from the Multicenter AIDS Cohort Study (MACS).
    AIDS Res Hum Retroviruses. 2023 Jun 5. doi: 10.1089/AID.2023.0001.
    PubMed     Abstract available
    
    
    May 2023
48. HAILE A, Tantu T, Kolato S
    Level Of ART Adherence and associated factors among People Living with HIV in the Context of Early Antiretroviral therapy initiation In Wolaita Sodo Town, Ethiopia: Cross-sectional study.
    AIDS Res Hum Retroviruses. 2023 May 27. doi: 10.1089/AID.2022.0100.
    PubMed     Abstract available
    
    
    
49. RAO E, Taylor J, Kaytes A, Smith D, et al
    Vulnerability in biomedical research: a historical reflection and practical implications for HIV cure-related research.
    AIDS Res Hum Retroviruses. 2023 May 25. doi: 10.1089/AID.2022.0136.
    PubMed     Abstract available
    
    
    
50. GUO X, Liu M, Wang C, Wang Y, et al
    The Long terminal repeat (LTR) sequence of Subtype C and CRF01_AE recombinants in China.
    AIDS Res Hum Retroviruses. 2023 May 14. doi: 10.1089/AID.2022.0175.
    PubMed     Abstract available
    
    
    
51. CAO B, Liu M, Jiang T, Yu Q, et al
    HIV-1 RNA and DNA genotyping drug resistance detection in patients with low-level viremia in Liangshan, China.
    AIDS Res Hum Retroviruses. 2023 May 14. doi: 10.1089/AID.2022.0140.
    PubMed     Abstract available
    
    
    
52. MEKURIA AD, Meseret W, Assefa HK, Sisay A, et al
    Time to Virological failure and it's predictor among HIV positive clients with the differentiated service delivery model of HIV at Debre Berhan Comprehensive Specialized Hospital, Amhara Regional state, Ethiopia, 2021: A retrospective cohort study.
    AIDS Res Hum Retroviruses. 2023 May 14. doi: 10.1089/AID.2022.0153.
    PubMed     Abstract available
    
    
    
53. ROCHA SQ, Fonsi M, Tancredi MV, Ramos de Alencar HD, et al
    Mpox in a couple living with HIV: relapse or reinfection?
    AIDS Res Hum Retroviruses. 2023 May 4. doi: 10.1089/AID.2022.0189.
    PubMed     Abstract available
    
    
    
54. LAHIRI CD, Mehta CC, Sykes C, Weiser SD, et al
    Obesity Modifies the Relationship Between Raltegravir and Dolutegravir Hair Concentrations and Body Weight Gain in Women Living with HIV.
    AIDS Res Hum Retroviruses. 2023 May 4. doi: 10.1089/AID.2022.0185.
    PubMed     Abstract available
    
    
    
55. ISLAM JY, Yang S, Schabath M, Vadaparampil S, et al
    Lung Cancer Screening Adherence Among People with HIV Treated at an Integrated Health System in Florida.
    AIDS Res Hum Retroviruses. 2023 May 3. doi: 10.1089/AID.2022.0158.
    PubMed     Abstract available
    
    
    April 2023
56. SANDERS-BEER BE, Archin NM, Brumme ZL, Busch M, et al
    Current HIV/SIV Reservoir Assays for Preclinical and Clinical Applications: Recommendations from the Experts 2022 NIAID Workshop Summary.
    AIDS Res Hum Retroviruses. 2023 Apr 26. doi: 10.1089/AID.2022.0188.
    PubMed     Abstract available
    
    
    
57. MARQUIS KA, Everett JK, Cantu VA, McFarland AG, et al
    The HIV-1 Capsid-Targeted Inhibitor GSK878 Alters Selection of Target Sites for HIV DNA Integration.
    AIDS Res Hum Retroviruses. 2023 Apr 26. doi: 10.1089/AID.2022.0161.
    PubMed     Abstract available
    
    
    
58. KROLL K, Woolley G, Terry K, Premeaux T, et al
    Multiplex analysis of cytokines and chemokines in persons aging with or without HIV.
    AIDS Res Hum Retroviruses. 2023 Apr 25. doi: 10.1089/AID.2022.0183.
    PubMed     Abstract available
    
    
    
59. PEREZ BARRAGAN E, Guevara Maldonado MF, Mancilla Galindo J, Kammar Garcia A, et al
    Weight gain after 12 months of switching to bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed HIV patients.
    AIDS Res Hum Retroviruses. 2023 Apr 18. doi: 10.1089/AID.2022.0130.
    PubMed     Abstract available
    
    
    
60. PILKINGTON V, Quinn K, Campbell LJ, Payne L, et al
    CLINICAL PRESENTATION OF MPOX IN PEOPLE WITH AND WITHOUT HIV IN THE UNITED KINGDOM DURING THE 2022 GLOBAL OUTBREAK.
    AIDS Res Hum Retroviruses. 2023 Apr 18. doi: 10.1089/AID.2023.0014.
    PubMed     Abstract available
    
    
    
61. ATKINSON B, Abbasi A, Sajadi MM, Tehrani ZR, et al
    Replacement of ART with HIV Broadly Neutralizing Antibodies to Maximize the Effectiveness of Chemotherapy in HIV Patients with Lung Cancer.
    AIDS Res Hum Retroviruses. 2023 Apr 13. doi: 10.1089/AID.2022.0181.
    PubMed     Abstract available
    
    
    
62. LI C, Sun J, Wang N, Yan P, et al
    Plasma Cytokine Expression and Immune Reconstitution in Early and Delayed Anti-HIV 96-Weeks Treatment - A Retrospective Study.
    AIDS Res Hum Retroviruses. 2023 Apr 12. doi: 10.1089/AID.2022.0089.
    PubMed     Abstract available
    
    
    
63. VANETTI C, Milazzo L, Ardizzone F, Oreni L, et al
    Humoral and cellular immune response elicited by two doses of mRNA BNT162b2 vaccine against SARS-CoV-2 in people living with HIV (PLWH).
    AIDS Res Hum Retroviruses. 2023 Apr 8. doi: 10.1089/AID.2022.0132.
    PubMed     Abstract available
    
    
    
64. DU R, Huang J
    Machine learning revealed a novel ferroptosis-based classification for diagnosis in antiretroviral therapy-treated HIV patients with defective immune recovery.
    AIDS Res Hum Retroviruses. 2023 Apr 8. doi: 10.1089/AID.2022.0138.
    PubMed     Abstract available
    
    
    
65. MORGAN E, Manuzak JA, Broedlow C, Hudson H, et al
    Problematic Cannabis Use Is Associated with Reduced Rectal Microbial Species Richness and Diversity Among a Pilot Sample of Young Sexual and Gender Minorities.
    AIDS Res Hum Retroviruses. 2023 Apr 5. doi: 10.1089/aid.2022.0143.
    PubMed     Abstract available
    
    
    
66. BARNABLE PJ, Mukhopadhyay S, Kizima L, Kumar N, et al
    Ex vivo colonic tissue susceptibility to HIV-1 in cisgender men and women.
    AIDS Res Hum Retroviruses. 2023 Apr 1. doi: 10.1089/AID.2022.0133.
    PubMed     Abstract available
    
    
    
67. SAMPAIO GCL, Ribeiro JR, de Almeida CN, Boa-Sorte N, et al
    Human T Cell Lymphotropic Virus Type 1 Global Prevalence Associated with the Human Development Index: Systematic Review with Meta-Analysis.
    AIDS Res Hum Retroviruses. 2023;39:145-165.
    PubMed     Abstract available
    
    
    March 2023
68. LI Z, Kang Q, Liu Y, Jia L, et al
    Identification of two Novel HIV-1 Second-generation Recombinant Forms (CRF01_AE/CRF07_BC) in Men Who Have Sex with Men in Hebei, China.
    AIDS Res Hum Retroviruses. 2023 Mar 21. doi: 10.1089/AID.2022.0131.
    PubMed     Abstract available
    
    
    
69. CAO X, Cao J, Qi H, Yu W, et al
    Prevalence of primary drug resistance among newly diagnosed HIV-1 infected individuals in Hunan province, China.
    AIDS Res Hum Retroviruses. 2023 Mar 16. doi: 10.1089/AID.2022.0077.
    PubMed     Abstract available
    
    
    
70. ZHANG X, Wang Y, An N, Tang X, et al
    Near-full-length genomic characteristics of three novel HIV-1 CRF01_AE/C recombinant forms among men who have sex with men in Hebei province, China.
    AIDS Res Hum Retroviruses. 2023 Mar 16. doi: 10.1089/AID.2022.0173.
    PubMed     Abstract available
    
    
    
71. KOUAMOU V, Gundidza P, Ndhlovu CE, Makadzange AT, et al
    Effects of Gender and Baseline CD4 Count on Post Treatment CD4 Count Recovery and Outcomes in Patients with Advanced HIV Disease: a Retrospective Cohort Study.
    AIDS Res Hum Retroviruses. 2023 Mar 16. doi: 10.1089/AID.2022.0117.
    PubMed     Abstract available
    
    
    
72. YOU Q, Qiao J, Peng Q, Li W, et al
    HIV-1 infection promotes cholesterol aggregation by inducing miR-33b-5p to suppress ABCA1 expression.
    AIDS Res Hum Retroviruses. 2023 Mar 16. doi: 10.1089/AID.2022.0152.
    PubMed     Abstract available
    
    
    
73. LI J, Dai M, Song B, Lu H, et al
    Genetic characteristics of two unique recombinant forms of HIV-1 CRF01_AE/CRF07_BC by near full-length genome from men who have sex with men in Beijing, China.
    AIDS Res Hum Retroviruses. 2023 Mar 16. doi: 10.1089/AID.2022.0164.
    PubMed     Abstract available
    
    
    
74. CAVALCANTE MG, Gomes PEAC, Parente MSR, Meneses GC, et al
    Monitoring renal function in HIV patients without kidney disease using endothelial biomarkers: a prospective pilot study.
    AIDS Res Hum Retroviruses. 2023 Mar 16. doi: 10.1089/AID.2022.0113.
    PubMed     Abstract available
    
    
    
75. MOUSAVI T, Moosazadeh M
    Association of hospitalization rate, mortality and CD4 T cell count with comorbidity of COVID-19 and HIV: A systematic review and meta-analysis.
    AIDS Res Hum Retroviruses. 2023 Mar 16. doi: 10.1089/AID.2022.0076.
    PubMed     Abstract available
    
    
    
76. HERNANDEZ-SALAZAR P, Ortiz-Rodriguez A, Garcia-Fuentes NB, Martinez-Salazar MF, et al
    Physical activity, anxiety, depression, and adherence to antiretroviral therapy in people with HIV.
    AIDS Res Hum Retroviruses. 2023 Mar 1. doi: 10.1089/AID.2022.0064.
    PubMed     Abstract available
    
    
    February 2023
77. ARAVANTINOU M, Plagianos M, Kokogho A, Adebajo S, et al
    HSV-2 prevalence and association with inflammatory cytokines among sexual and gender minorities (SGM) living with and without HIV-1 from Lagos, Nigeria.
    AIDS Res Hum Retroviruses. 2023 Feb 24. doi: 10.1089/AID.2022.0070.
    PubMed     Abstract available
    
    
    
78. RACHEL G, Vembuli H, Kumar C P G, Hanna LE, et al
    Immune cell cross talk in the establishment of HIV-1 latency.
    AIDS Res Hum Retroviruses. 2023 Feb 24. doi: 10.1089/AID.2022.0062.
    PubMed     Abstract available
    
    
    
79. DE SCHACHT C, Amorim G, Van Rompaey S, Melo M, et al
    Favorable Impact of Community Adherence Support Groups on Retention in Care and Viral Suppression Rates among Persons with HIV Receiving Antiretroviral Therapy in Mozambique.
    AIDS Res Hum Retroviruses. 2023 Feb 18. doi: 10.1089/AID.2022.0149.
    PubMed     Abstract available
    
    
    
80. MURENZI G, Kim HY, Shi Q, Muhoza B, et al
    Association between Time to Antiretroviral Therapy and Loss to Care Among Newly Diagnosed Rwandan People Living with Human Immunodeficiency Virus.
    AIDS Res Hum Retroviruses. 2023 Feb 18. doi: 10.1089/AID.2022.0023.
    PubMed     Abstract available
    
    
    
81. MASTERS MC, Granche J, Yang J, Overton ET, et al
    Association between metformin use and cognitive and physical function in persons with HIV and diabetes.
    AIDS Res Hum Retroviruses. 2023 Feb 15. doi: 10.1089/AID.2022.0129.
    PubMed     Abstract available
    
    
    
82. HALLMARK CJ, Luswata C, Del Vecchio N, Hayford C, et al
    Predictors of HIV Molecular Cluster Membership and Implications for Partner Services.
    AIDS Res Hum Retroviruses. 2023 Feb 13. doi: 10.1089/AID.2022.0088.
    PubMed     Abstract available
    
    
    
83. DUBIC MG, Edwards S, McDaniel LS, Simon L, et al
    Differential regulation of tachykinin and opioid system gene expression in brain and immune cells of chronic binge alcohol-treated, simian immunodeficiency virus (SIV)-infected macaques.
    AIDS Res Hum Retroviruses. 2023 Feb 10. doi: 10.1089/AID.2022.0122.
    PubMed     Abstract available
    
    
    
84. BASU M, Fucile C, Piepenbrink M, Bunce C, et al
    Mixed Origins: HIV gp120-specific memory develops from pre-existing memory and naive B cells following vaccination in humans.
    AIDS Res Hum Retroviruses. 2023 Feb 10. doi: 10.1089/AID.2022.0104.
    PubMed     Abstract available
    
    
    
85. OOMEN PGA, Hakkers CS, Arends J, van den Berk G, et al
    The effect of efavirenz on reward processing in asymptomatic people living with HIV: a randomized controlled trial.
    AIDS Res Hum Retroviruses. 2023 Feb 3. doi: 10.1089/AID.2022.0069.
    PubMed     Abstract available
    
    
    January 2023
86. LIU M, Jia L, Guo X, Zhai X, et al
    Identification and characterization of the HERV-K (HML-8) group of human endogenous retroviruses in the genome.
    AIDS Res Hum Retroviruses. 2023 Jan 19. doi: 10.1089/AID.2022.0084.
    PubMed     Abstract available
    
    
    
87. WATERS AV, Dorsey K, Allston A, Woods A, et al
    Risk Factors for HPV-Associated Cancers among People Living with HIV in Washington, DC.
    AIDS Res Hum Retroviruses. 2023 Jan 19. doi: 10.1089/AID.2022.0128.
    PubMed     Abstract available
    
    
    
88. KHAIRUNISA SQ, Megasari NLA, Ueda S, Kotaki T, et al
    Subtype distribution and drug resistance patterns among HIV-1 strains prevalent in Makassar, Indonesia.
    AIDS Res Hum Retroviruses. 2023 Jan 19. doi: 10.1089/AID.2022.0139.
    PubMed     Abstract available
    
    
    
89. SANTORO AF, Ferraris CM, Aghvinian M, Aurpibul L, et al
    Acceptability and Feasibility of Genetic Testing to Assess Risk of HIV-Associated Neurocognitive Impairment among Thai Adolescents and Young Adults.
    AIDS Res Hum Retroviruses. 2023 Jan 6. doi: 10.1089/AID.2022.0060.
    PubMed     Abstract available
    
    
    
90. BELAUNZARAN-ZAMUDIO PF, Naranjo L, Caro-Vega Y, Castillo-Mancilla JR, et al
    Incomplete ART Adherence Is Associated with Lower CD4-CD8 Ratio in Virally Suppressed Patients with HIV-infection in Mexico.
    AIDS Res Hum Retroviruses. 2023 Jan 3. doi: 10.1089/AID.2021.0179.
    PubMed     Abstract available
    
    
    
91. RAMOS-RUPERTO L, Busca-Arenzana C, Diez-Vidal A, Robles-Marhuenda A, et al
    PREVALENCE AND TEMPORAL TRENDS OF AUTOIMMUNE DISEASES IN PEOPLE LIVING WITH HIV.
    AIDS Res Hum Retroviruses. 2023 Jan 3. doi: 10.1089/AID.2022.0090.
    PubMed     Abstract available
    
    
    December 2022
92. WILSON A, Manuzak J, Liang H, Leda AR, et al
    Probiotic therapy during vaccination alters antibody response to SHIV infection but not to commensals.
    AIDS Res Hum Retroviruses. 2022 Dec 14. doi: 10.1089/AID.2022.0123.
    PubMed     Abstract available
    
    
    
93. TAO K, Rhee SY, Tzou PL, Holmes S, et al
    Highly Ambiguous HIV-1 pol Positions Encoding Multiple Amino Acids Usually Result from Antiviral or Immune Selection Pressure.
    AIDS Res Hum Retroviruses. 2022 Dec 14. doi: 10.1089/AID.2022.0094.
    PubMed     Abstract available
    
    
    
94. SINGTOROJ T, Teeraananchai S, Chokephaibulkit K, Phanuphak N, et al
    Factors associated with morbidity and mortality among sexually active Asian adolescents and young adults with perinatally acquired HIV.
    AIDS Res Hum Retroviruses. 2022 Dec 14. doi: 10.1089/AID.2021.0169.
    PubMed     Abstract available
    
    
    
95. WALMSLEY S, Clarke R, Lee T, Singer J, et al
    BEING: Bone Health in Aging Women with HIV: Impact of Switching Antiretroviral Therapy on Bone Mineral Density During the Peri-menopausal period.
    AIDS Res Hum Retroviruses. 2022 Dec 13. doi: 10.1089/AID.2022.0106.
    PubMed     Abstract available
    
    
    
96. BRICENO O, Peralta-Prado A, Garrido-Rodriguez D, Romero-Mora K, et al
    Double negative T cell number and phenotype alterations before and after effective antiretroviral treatment in persons living with HIV.
    AIDS Res Hum Retroviruses. 2022 Dec 13. doi: 10.1089/AID.2022.0047.
    PubMed     Abstract available
    
    
    
97. MISHRA S, Taneja S, De A, Verma N, et al
    Efficacy, tolerability and compliance of direct acting antivirals in patients with HIV and Hepatitis C co-infection: A real-life experience.
    AIDS Res Hum Retroviruses. 2022 Dec 13. doi: 10.1089/AID.2022.0034.
    PubMed     Abstract available
    
    
    
98. SHANGGUAN S, Ehrenberg PK, Geretz A, Butler L, et al
    HLA-B*57 and B*58 associate with predictors of reservoir size in an acutely treated HIV cohort.
    AIDS Res Hum Retroviruses. 2022 Dec 5. doi: 10.1089/AID.2022.0082.
    PubMed     Abstract available
    
    
    
99. PUCCIONI-SOHLER M, Poton AR, Cabral-Castro MJ, Yamano Y, et al
    Human T Lymphotropic Virus 1-Associated Myelopathy: Overview of Human T Cell Lymphotropic Virus-1/2 Tests and Potential Biomarkers.
    AIDS Res Hum Retroviruses. 2022;38:924-932.
    PubMed     Abstract available
    
    
    November 2022
100. SINGH I, Tzipori S
     An SIV-Infected Macaque Model of Enterocytozoon bieneusi Infection.
     AIDS Res Hum Retroviruses. 2022 Nov 24. doi: 10.1089/AID.2022.0091.
     PubMed     Abstract available
     
     
     
101. LEAL L, Guardo AC, Bedoya LM, Rodriguez de Miguel C, et al
     Pharmacokinetics, the immunological impact and the effect on HIV ex-vivo infectivity of maraviroc, raltegravir and lopinavir in MSM using Post-exposure Prophylaxis.
     AIDS Res Hum Retroviruses. 2022 Nov 23. doi: 10.1089/AID.2021.0232.
     PubMed     Abstract available
     
     
     
102. MOSCHOPOULOS C, Protopapas K, Thomas K, Kavatha D, et al
     Switching from tenofovir disoproxil to tenofovir alafenamide fumarate: Impact on cardiovascular risk and lipid profile in people living with HIV, an observational single-center study.
     AIDS Res Hum Retroviruses. 2022 Nov 18. doi: 10.1089/AID.2022.0086.
     PubMed     Abstract available
     
     
     
103. TANG X, Liu M, An N, Zhang X, et al
     Identification of two novel HIV-1 recombinant forms originated from CRF01_AE and subtype B in the sexual contact population in Hebei province, China.
     AIDS Res Hum Retroviruses. 2022 Nov 18. doi: 10.1089/AID.2022.0124.
     PubMed     Abstract available
     
     
     
104. YOUNG PW, Musingila P, Kingwara L, Voetsch D, et al
     HIV incidence, recent HIV infection, and associated factors, Kenya, 2007-2018.
     AIDS Res Hum Retroviruses. 2022 Nov 18. doi: 10.1089/AID.2022.0054.
     PubMed     Abstract available
     
     
     
105. JOHN D, Wang P, Togo Y, McGovern M, et al
     Global imbalances in funding sources for HIV randomized control trials.
     AIDS Res Hum Retroviruses. 2022 Nov 18. doi: 10.1089/AID.2022.0068.
     PubMed     Abstract available
     
     
     
106. RUHANYA V, Jacobs GB, Paul RH, Joska J, et al
     HIV-1 subtype C Vpr amino acid residue 45Y and specific conserved fragments are associated with neurocognitive impairment and markers of viral load.
     AIDS Res Hum Retroviruses. 2022 Nov 18. doi: 10.1089/AID.2022.0022.
     PubMed     Abstract available
     
     
     
107. FAILLA M, Pasquali E, Galli L, Chiappini E, et al
     Integrase strand transfer inhibitors use in children with perinatal HIV-1 infection: a narrative review.
     AIDS Res Hum Retroviruses. 2022 Nov 9. doi: 10.1089/AID.2022.0039.
     PubMed     Abstract available
     
     
     
108. YU X, Lobo JD, Sundermann E, Baker DJ, et al
     Current Challenges and Solutions for Clinical Management and Care of People with HIV: Findings from the 12th Annual International HIV and Aging Workshop.
     AIDS Res Hum Retroviruses. 2022 Nov 2. doi: 10.1089/AID.2022.0079.
     PubMed     Abstract available
     
     
     
109. LOPEZ JM, Rael CT
     The Continued Importance of Including Transgender Individuals in HIV-Related Research.
     AIDS Res Hum Retroviruses. 2022;38:831-833.
     PubMed    
     
     
     
110. IANNONE V, Farinacci D, D'Angelillo A, Dusina A, et al
     Cardiovascular Disease Risk in a Cohort of Virologically Suppressed People Living with HIV Switching to Doravirine: Preliminary Data from the Real Life.
     AIDS Res Hum Retroviruses. 2022;38:878-880.
     PubMed     Abstract available
     
     
     October 2022
111. FERRUFINO RQ, Bierrenbach AL, Rodrigues C, Figueiredo GM, et al
     The Changing Epidemiology of Hepatitis C Virus Acquisition among HIV-infected individuals in Brazil.
     AIDS Res Hum Retroviruses. 2022 Oct 27. doi: 10.1089/AID.2021.0197.
     PubMed     Abstract available
     
     
     
112. ADACHI E, Ikeuchi K, Koga M, Yotsuyanagi H, et al
     Changes in inflammatory biomarkers when switching from from 3-drug regimens to dolutegravir plus lamivudine in people living with HIV.
     AIDS Res Hum Retroviruses. 2022 Oct 27. doi: 10.1089/AID.2022.0115.
     PubMed     Abstract available
     
     
     
113. ANDRADE A, Fuchs EJ, Marzinke MA, Abdul Massih S, et al
     EVG/COBI/FTC/TAF BIOEQUIVALENCE COMPARING WHOLE TABLETS TO TABLETS DISSOLVED IN TAP WATER.
     AIDS Res Hum Retroviruses. 2022 Oct 27. doi: 10.1089/AID.2022.0085.
     PubMed     Abstract available
     
     
     
114. GRINSTEINER E, Morrow M, MaWhinney S, Coyle R, et al
     Demographic and clinical characteristics of persons with HIV with viral load:adherence mismatch who are at risk of future viremia.
     AIDS Res Hum Retroviruses. 2022 Oct 27. doi: 10.1089/AID.2021.0218.
     PubMed     Abstract available
     
     
     
115. SAYAN M, Sultanoglu N, Sanlidag T
     Dynamics of Rilpivirine Resistance Associated Mutation - E138 in Reverse Transcriptase among Antiretroviral-Naive HIV-1 Infected Individuals in Turkey.
     AIDS Res Hum Retroviruses. 2022 Oct 27. doi: 10.1089/AID.2022.0065.
     PubMed     Abstract available
     
     
     
116. SU QJ, Jiang H, Zhang Y, Huang LJ, et al
     Smad2/3 phosphorylation is down-regulated in T cells in HIV-infected patients.
     AIDS Res Hum Retroviruses. 2022 Oct 13. doi: 10.1089/AID.2021.0212.
     PubMed     Abstract available
     
     
     
117. SANTANA DS, Silva MJA, de Marin ABR, Costa VLDS, et al
     The influence Between C-C Chemokine Receptor 5 (CCR5) Genetic Polymorphisms and the Type-1 Human Immunodeficiency Virus (HIV-1): a 20 years review.
     AIDS Res Hum Retroviruses. 2022 Oct 13. doi: 10.1089/AID.2022.0111.
     PubMed     Abstract available
     
     
     
118. ZHOU XY, Li CX, Zhang JB, Tan JT, et al
     Association of human leukocyte antigen alleles and hypersensitivity of Efavirenz/Nevirapine in HIV-infected Chinese patients.
     AIDS Res Hum Retroviruses. 2022 Oct 13. doi: 10.1089/AID.2022.0027.
     PubMed     Abstract available
     
     
     
119. DUBE K, Campbell C, Eskaf S, Sauceda JA, et al
     Willingness of Racially Diverse Young Adults Living with HIV to Participate in HIV Cure Research: A Cross-Sectional Survey in the United States.
     AIDS Res Hum Retroviruses. 2022 Oct 13. doi: 10.1089/AID.2022.0005.
     PubMed     Abstract available
     
     
     
120. GARCIA M, Martellosio JP, Giraud V, Beraud G, et al
     Efficacy and Safety of Doravirine-Based Regimens in Real Life: A Prospective Monocentric French Study.
     AIDS Res Hum Retroviruses. 2022;38:779-781.
     PubMed     Abstract available
     
     
     September 2022
121. TAGLIAFERRI RAEL C, Giguere R, Sutton S, Horn E, et al
     Preferences for a Long-Acting, Removable Implant for HIV Prevention among MSM and Physicians: A Discrete Choice Study.
     AIDS Res Hum Retroviruses. 2022 Sep 30. doi: 10.1089/AID.2022.0035.
     PubMed     Abstract available
     
     
     
122. ZHAO R, Ma R, Zhao C, Zhang Q, et al
     Risk factors for Osteonecrosis of the femoral head in HIV positive patients: A retrospective case-control study.
     AIDS Res Hum Retroviruses. 2022 Sep 27. doi: 10.1089/AID.2021.0224.
     PubMed     Abstract available
     
     
     
123. SHARAFI M, Mirahmadizadeh A, Hassanzadeh J, Seif M, et al
     Prevalence of Late Presenters and Advanced HIV disease in HIV patients and their related factors in Iran: Results from 19 years of national surveillance HIV data.
     AIDS Res Hum Retroviruses. 2022 Sep 27. doi: 10.1089/AID.2022.0046.
     PubMed     Abstract available
     
     
     
124. RUIZ-MANRIQUEZ CA, Hernandez-Ruiz VA, Crabtree-Ramirez BE, Amieva H, et al
     A lower CD4+/CD8+ ratio predicts activities of daily living decline among older adults with HIV.
     AIDS Res Hum Retroviruses. 2022 Sep 22. doi: 10.1089/AID.2022.0080.
     PubMed     Abstract available
     
     
     
125. RIPAMONTI D, Poliseno M, Mazzola G, Colletti P, et al
     Perceptions of U=U among Italian Infectious Diseases Specialists: a nationwide survey on providers' attitudes towards the risk of HIV transmission in virologically suppressed patients.
     AIDS Res Hum Retroviruses. 2022 Sep 13. doi: 10.1089/AID.2022.0056.
     PubMed     Abstract available
     
     
     
126. LANTZ A, Nicol MR
     Translational Models to Predict Target Concentrations for Pre-Exposure Prophylaxis in Women.
     AIDS Res Hum Retroviruses. 2022 Sep 13. doi: 10.1089/AID.2022.0057.
     PubMed     Abstract available
     
     
     August 2022
127. NEERGAARD R, Jones NL, Roebuck C, Rendle KA, et al
     "I know that I was a part of making a difference": Participant motivations for joining a cure-directed HIV trial with an analytical treatment interruption.
     AIDS Res Hum Retroviruses. 2022 Aug 18. doi: 10.1089/AID.2022.0040.
     PubMed     Abstract available
     
     
     
128. YEAGER S, Montoya JL, Burke L, Chow K, et al
     Patient and physician preferences regarding long-acting pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART): A mixed-methods study in Southern California, USA.
     AIDS Res Hum Retroviruses. 2022 Aug 16. doi: 10.1089/AID.2022.0029.
     PubMed     Abstract available
     
     
     
129. DUBE K, Agarwal H, Stockman JK, Auerbach JD, et al
     "I would absolutely need to know that my partner is still going to be protected": Perceptions of HIV Cure-Related Research among Diverse HIV Serodifferent Couples in the United States.
     AIDS Res Hum Retroviruses. 2022 Aug 16. doi: 10.1089/AID.2022.0036.
     PubMed     Abstract available
     
     
     
130. WANG X, Chen M, Ma S, Ding Y, et al
     HIV-1 Tat protein-mediated inflammatory response inhibits the erythroid hematopoietic support function of bone marrow mesenchymal stem cells.
     AIDS Res Hum Retroviruses. 2022 Aug 16. doi: 10.1089/AID.2022.0011.
     PubMed     Abstract available
     
     
     
131. HERNANDEZ-RUIZ VA, Erlandson KM, Amieva H, Avila-Funes JA, et al
     VACS index and Frailty: one part of the whole.
     AIDS Res Hum Retroviruses. 2022 Aug 16. doi: 10.1089/AID.2022.0075.
     PubMed     Abstract available
     
     
     
132. WEERASURIA M, Ko C, Ehm A, O'Bryan J, et al
     The impact of the COVID-19 pandemic on people with HIV in Victoria, Australia: 1 year later.
     AIDS Res Hum Retroviruses. 2022 Aug 16. doi: 10.1089/AID.2022.0048.
     PubMed     Abstract available
     
     
     
133. YU D, Liang B, Yang Y, Liu J, et al
     Prevalence of drug resistance and genetic transmission networks among HIV/AIDS patients with antiretroviral therapy failure in Guangxi, China.
     AIDS Res Hum Retroviruses. 2022 Aug 16. doi: 10.1089/AID.2021.0181.
     PubMed     Abstract available
     
     
     
134. KOUAMOU V, Machekano R, Mapangisana T, Maposhere C, et al
     Tenofovir, Lamivudine and Dolutegravir (TLD) among Rural Adolescents in Zimbabwe, a Cautionary Tale.
     AIDS Res Hum Retroviruses. 2022 Aug 12. doi: 10.1089/AID.2021.0140.
     PubMed     Abstract available
     
     
     
135. FENG L, Chen T, Zhang J, Wang Q, et al
     Clinical characteristics and outcomes of chronic kidney disease in people living with HIV in a resource limited centre of central China.
     AIDS Res Hum Retroviruses. 2022 Aug 11. doi: 10.1089/AID.2022.0009.
     PubMed     Abstract available
     
     
     
136. YAGER J, Brooks KM, Brothers J, Mulligan K, et al
     Pharmacokinetics of emtricitabine/tenofovir disoproxil fumarate among transgender adolescents and young adults without HIV receiving gender affirming hormones.
     AIDS Res Hum Retroviruses. 2022 Aug 9. doi: 10.1089/AID.2022.0043.
     PubMed     Abstract available
     
     
     
137. HSU R, Brunet L, Fusco JS, Mounzer K, et al
     Excessive weight gain: current antiretroviral agents in virologically suppressed people with HIV.
     AIDS Res Hum Retroviruses. 2022 Aug 3. doi: 10.1089/AID.2021.0188.
     PubMed     Abstract available
     
     
     
138. PARMLEY LE, Harris TG, Hakim AJ, Musuka G, et al
     Recent HIV infection among men who have sex with men, transgender women, and genderqueer individuals with newly diagnosed HIV infection in Zimbabwe: Results from a respondent-driven sampling survey.
     AIDS Res Hum Retroviruses. 2022 Aug 3. doi: 10.1089/AID.2021.0216.
     PubMed     Abstract available
     
     
     July 2022
139. LU X, Li Y, Wang Y, An N, et al
     Identification of a new HIV-1 CRF68_01B/CRF01_AE recombinant form among men who have sex with men in Hebei province, China.
     AIDS Res Hum Retroviruses. 2022 Jul 29. doi: 10.1089/AID.2022.0067.
     PubMed     Abstract available
     
     
     
140. CASSEB J, Lopes LR
     Reflection about the ancient emergence of HTLV-2 infection: Potential for endogenization.
     AIDS Res Hum Retroviruses. 2022 Jul 14. doi: 10.1089/AID.2022.0019.
     PubMed     Abstract available
     
     
     
141. LANZAFAME M, Rizzardo S, Lattuada E, Luise D, et al
     Dolutegravir monotherapy and weight gain in naive patients with <100,000 copies/ml HIV RNA:an extended follow-up.
     AIDS Res Hum Retroviruses. 2022 Jul 10. doi: 10.1089/AID.2021.0234.
     PubMed     Abstract available
     
     
     
142. YAGER J, Brooks KM, Brothers J, Mulligan K, et al
     Gender-affirming hormone pharmacokinetics among adolescent and young adult transgender persons receiving daily F/TDF.
     AIDS Res Hum Retroviruses. 2022 Jul 10. doi: 10.1089/AID.2022.0044.
     PubMed     Abstract available
     
     
     
143. FAN W, Liu Y, Li Y, Su M, et al
     Identi fi cation of Three Novel HIV-1 Second-Generation Recombinant Forms (CRF01_AE/CRF07_BC) Among MSM in Baoding, Hebei, China.
     AIDS Res Hum Retroviruses. 2022 Jul 10. doi: 10.1089/AID.2022.0037.
     PubMed     Abstract available
     
     
     
144. SIDDIQUI M, Moore TJ, Long DM, Burkholder GA, et al
     Risk factors for incident hypertension within one year of initiating antiretroviral therapy among people with HIV.
     AIDS Res Hum Retroviruses. 2022 Jul 1. doi: 10.1089/AID.2021.0213.
     PubMed     Abstract available
     
     
     
145. ABIDI SH, Siddiqui D, Mahmood SF, Siddiqui R, et al
     Unassigned complex unique recombinant forms related to CRF36_cpx in children identified in an HIV-1 outbreak in Pakistan.
     AIDS Res Hum Retroviruses. 2022 Jul 1. doi: 10.1089/AID.2021.0168.
     PubMed     Abstract available
     
     
     
146. BOATENG AT, Abaidoo-Myles A, Bonney EY, Kyei GB, et al
     Isoform selective versus non-selective histone deacetylase inhibitors in HIV latency reversal.
     AIDS Res Hum Retroviruses. 2022 Jul 1. doi: 10.1089/AID.2021.0195.
     PubMed     Abstract available
     
     
     
147. TOEQUE MG, Lindsay B, Zulu PM, Hachaambwa L, et al
     Treatment-Experienced Patients on Third-Line Therapy: A Retrospective Cohort of Treatment Outcomes at the HIV Advanced Treatment Centre, University Teaching Hospital, Zambia.
     AIDS Res Hum Retroviruses. 2022 Jul 1. doi: 10.1089/AID.2021.0208.
     PubMed     Abstract available
     
     
     
148. LESSARD D, Dube K, Bilodeau M, Keeler P, et al
     Willingness of older Canadians with HIV to participate in HIV cure research near and after the end-of-life: A mixed-method study.
     AIDS Res Hum Retroviruses. 2022 Jul 1. doi: 10.1089/AID.2022.0006.
     PubMed     Abstract available
     
     
     June 2022
149. ARIYANTO I, Estiasari R, Lee S, Price P, et al
     gammadelta T-cell subpopulations associate with recovery of memory function in Indonesian HIV patients starting ART.
     AIDS Res Hum Retroviruses. 2022 Jun 14. doi: 10.1089/AID.2021.0171.
     PubMed     Abstract available
     
     
     
150. LIU S, Yan Q, Xiao M, Jiang Y, et al
     The impact of frailty on all-cause mortality in patients with HIV infection: A systematic review and meta-analysis.
     AIDS Res Hum Retroviruses. 2022 Jun 4. doi: 10.1089/AID.2021.0155.
     PubMed     Abstract available
     
     
     
151. 
     Call for Special Issue Papers: HIV Research Towards a Cure.
     AIDS Res Hum Retroviruses. 2022;38:431-432.
     PubMed    
     
     
     May 2022
152. SHRESTHA I, Ming K, Jimenez V, Wendelborn J, et al
     Lessons learned from an HIV pre-exposure prophylaxis coordination program in San Francisco primary care clinics.
     AIDS Res Hum Retroviruses. 2022 May 20. doi: 10.1089/AID.2022.0013.
     PubMed     Abstract available
     
     
     
153. DE SCHACHT C, Lucas C, Paulo P, Van Rompaey S, et al
     Reaching males and young adults in a pharmacy-based HIV self-testing strategy: Results from an acceptability study in Mozambique.
     AIDS Res Hum Retroviruses. 2022 May 17. doi: 10.1089/AID.2021.0116.
     PubMed     Abstract available
     
     
     
154. MALAMA K, Logie CH, Narasimhan M, Ouedraogo L, et al
     Short Communication vertical line Awareness of HIV self-care interventions across global regions: results from a values and preferences survey.
     AIDS Res Hum Retroviruses. 2022 May 17. doi: 10.1089/AID.2021.0200.
     PubMed     Abstract available
     
     
     
155. SABERI P, Campbell C, Sauceda JA, Ndukwe SO, et al
     Perceptions of risks and benefits of participating in HIV cure-related research among diverse young adults living with HIV in the United States: qualitative research findings.
     AIDS Res Hum Retroviruses. 2022 May 17. doi: 10.1089/AID.2021.0192.
     PubMed     Abstract available
     
     
     
156. TASHIRO Y, Matsuura E, Sagara Y, Nozuma S, et al
     High Prevalence of HTLV-1 Carriers Among the Elderly Population in Kagoshima, a Highly Endemic Area in Japan.
     AIDS Res Hum Retroviruses. 2022;38:363-369.
     PubMed     Abstract available
     
     
     April 2022
157. CAIRA-CHUQUINEYRA B, Fernandez-Guzman D, Soriano-Moreno DR, Fernandez-Morales J, et al
     Fecal microbiota transplantation for people living with HIV: A scoping review.
     AIDS Res Hum Retroviruses. 2022 Apr 22. doi: 10.1089/AID.2022.0016.
     PubMed     Abstract available
     
     
     
158. TEDALDI EM, Armon C, Li J, Mahnken J, et al
     A heavy burden: preexisting physical and psychiatric comorbidities, and differential increases among male and female participants after initiating antiretroviral therapy in the HIV Outpatient Study, 2008-2018.
     AIDS Res Hum Retroviruses. 2022 Apr 22. doi: 10.1089/AID.2021.0178.
     PubMed     Abstract available
     
     
     
159. FERGUSON N, Cogswell A, Barker E
     Contribution of Innate Lymphoid Cells in Supplementing Cytokines Produced by CD4+ T-cells During Acute and Chronic SIV Infection of the Colon.
     AIDS Res Hum Retroviruses. 2022 Apr 22. doi: 10.1089/AID.2022.0007.
     PubMed     Abstract available
     
     
     
160. NARVAEZ M, Lins-Kusterer L, Valdelamar-Jimenez J, Brites C, et al
     Quality of life and antiretroviral therapy adherence: A cross-sectional study in Colombia.
     AIDS Res Hum Retroviruses. 2022 Apr 22. doi: 10.1089/AID.2021.0233.
     PubMed     Abstract available
     
     
     
161. NJUHO PM, Haankuku UN
     HIV infection progression monitoring system based on CD4 counts and Wishart-distribution.
     AIDS Res Hum Retroviruses. 2022 Apr 18. doi: 10.1089/AID.2021.0118.
     PubMed     Abstract available
     
     
     
162. SCHINDLER S, Magalhaes RA, Costa ELF, Brites C, et al
     Genital cytokines in HIV/ human papillomavirus co-infection: a systematic review.
     AIDS Res Hum Retroviruses. 2022 Apr 18. doi: 10.1089/AID.2021.0139.
     PubMed     Abstract available
     
     
     
163. HE J, Liu X, Duan S, Ye R, et al
     Untargeted plasma metabolomics reveals extensive metabolic alterations among treatment naive HIV/HCV co-infected patients with liver disease progression.
     AIDS Res Hum Retroviruses. 2022 Apr 6. doi: 10.1089/AID.2021.0123.
     PubMed     Abstract available
     
     
     March 2022
164. RUBIN L, Neijna A, Shi Q, Hoover DR, et al
     Degree of polypharmacy and cognitive function in older women with HIV.
     AIDS Res Hum Retroviruses. 2022 Mar 31. doi: 10.1089/AID.2021.0231.
     PubMed     Abstract available
     
     
     
165. RUIZ-ALGUERO M, Alejos B, Garcia Yubero C, Riera Jaume M, et al
     Use of generic antiretroviral drugs and single-tablet regimen de-simplification for the treatment of HIV infection in Spain.
     AIDS Res Hum Retroviruses. 2022 Mar 31. doi: 10.1089/AID.2021.0122.
     PubMed     Abstract available
     
     
     
166. SANGARLANGKARN A, Apornpong T, Woodard J, Jordan A, et al
     Correlation Between Polypharmacy and Frailty Among Thai Older Persons Living with HIV.
     AIDS Res Hum Retroviruses. 2022 Mar 24. doi: 10.1089/AID.2021.0214.
     PubMed     Abstract available
     
     
     
167. DUBE K, Eskaf S, Barr L, Palm D, et al
     Participant Perspectives and Experiences Following an Intensively Monitored Antiretroviral Pause (IMAP) in the United States: Results from the AIDS Clinical Trials Group (ACTG) A5345 Biomarker Study.
     AIDS Res Hum Retroviruses. 2022 Mar 24. doi: 10.1089/AID.2021.0170.
     PubMed     Abstract available
     
     
     
168. KOAY WLA, Xiao J, Temprosa M, Happ LP, et al
     Outcomes of Dual Versus Triple Antiretroviral Drug Regimens Among Virally Suppressed Adults in the DC Cohort.
     AIDS Res Hum Retroviruses. 2022 Mar 23. doi: 10.1089/aid.2021.0202.
     PubMed     Abstract available
     
     
     
169. BOWMAN E, Wilson M, Riedl K, MaWhinney S, et al
     Lipidome alterations with exercise among people with and without HIV- an exploratory study.
     AIDS Res Hum Retroviruses. 2022 Mar 18. doi: 10.1089/AID.2021.0154.
     PubMed     Abstract available
     
     
     
170. KARUNAIANANTHAM R, Nesakumar M, Gopalan B, Haribabu H, et al
     Molecular characterisation of the pol gene of vertically transmitted HIV-1 strains in children with virological failure.
     AIDS Res Hum Retroviruses. 2022 Mar 18. doi: 10.1089/AID.2021.0227.
     PubMed     Abstract available
     
     
     
171. HARNPARIPHAN W, Han WM, Supanan R, Ubolyam S, et al
     High proportion of blood-borne and sexually transmitted infections among people deprived of liberty in a central male prison in Thailand: a cross-sectional study 2018-2019.
     AIDS Res Hum Retroviruses. 2022 Mar 9. doi: 10.1089/AID.2021.0134.
     PubMed     Abstract available
     
     
     
172. MCLIGEYO A, Wekesa P, Owuor K, Mwangi J, et al
     Factors associated with treatment outcomes among children and adolescents living with HIIV receiving antiretroviral therapy in central Kenya.
     AIDS Res Hum Retroviruses. 2022 Mar 1. doi: 10.1089/AID.2021.0112.
     PubMed     Abstract available
     
     
     
173. WEI Q, Zhao Y, Lv Y, Kang X, et al
     High rate of HIV-1 drug resistance in ART-failure patients in Liaoning Province, China.
     AIDS Res Hum Retroviruses. 2022 Mar 1. doi: 10.1089/AID.2021.0079.
     PubMed     Abstract available
     
     
     February 2022
174. BURNS CM, Borges M, Frye J, Keicher K, et al
     Understanding Retention in PrEP Care in the South: Insights from an Academic HIV Prevention Clinic.
     AIDS Res Hum Retroviruses. 2022 Feb 16. doi: 10.1089/AID.2021.0177.
     PubMed     Abstract available
     
     
     
175. TARAMASSO L, Lo Caputo S, Magnasco L, Briano F, et al
     Long-term effectiveness of rilpivirine-based single-tablet regimens in a seven-year two centers observational cohort of people living with HIV.
     AIDS Res Hum Retroviruses. 2022 Feb 16. doi: 10.1089/AID.2021.0161.
     PubMed     Abstract available
     
     
     
176. LI Y, Zhu B, Han J, Li J, et al
     Identification of Two Novel HIV-1 unique Recombinant Forms in Shenzhen, China.
     AIDS Res Hum Retroviruses. 2022 Feb 16. doi: 10.1089/AID.2021.0229.
     PubMed     Abstract available
     
     
     
177. KETELS T, Gisolf J, Claassen M, Swanink C, et al
     Prolonged COVID-19 infection in a patient with newly diagnosed HIV/AIDS.
     AIDS Res Hum Retroviruses. 2022 Feb 16. doi: 10.1089/AID.2021.0145.
     PubMed     Abstract available
     
     
     
178. ALMOMEN A, Cox J, Lebouche B, Cheng M, et al
     Ongoing impact of the social determinants of health during the second and third waves of the COVID-19 pandemic in People Living with HIV receiving care in a Montreal-based Tertiary Care Centre.
     AIDS Res Hum Retroviruses. 2022 Feb 16. doi: 10.1089/AID.2021.0186.
     PubMed     Abstract available
     
     
     
179. FULLER D, O'Connor MA
     Letter to the Editor on Guerriero et al.: Prior infection with coccidioidomycosis in nonhuman primates and impact on SIV disease and vaccine immunogenicity.
     AIDS Res Hum Retroviruses. 2022 Feb 16. doi: 10.1089/AID.2021.0236.
     PubMed     Abstract available
     
     
     
180. SPENCE AB, Liu C, Rubin L, Aouizerat B, et al
     Class-based antiretroviral exposure and cognition among women living with HIV (WLWH).
     AIDS Res Hum Retroviruses. 2022 Feb 2. doi: 10.1089/AID.2021.0097.
     PubMed     Abstract available
     
     
     
181. FAN W, Su M, Meng J, Yang X, et al
     Characterization of a New HIV-1 CRF01_AE/B Recombinant Virus Form Among Men Who Have Sex with Men inBaoding, Hebei,China.
     AIDS Res Hum Retroviruses. 2022 Feb 2. doi: 10.1089/AID.2021.0209.
     PubMed     Abstract available
     
     
     January 2022
182. OGUARIRI RM, Brann TW, Adelsberger JW, Chen Q, et al
     S100A8 and S100A9, biomarkers of SARS-CoV-2-infection and other diseases, suppress HIV replication in primary macrophages.
     AIDS Res Hum Retroviruses. 2022 Jan 19. doi: 10.1089/AID.2021.0193.
     PubMed     Abstract available
     
     
     
183. ZHU B, Zhao J, Wang X, Li H, et al
     Characterization of three Novel HIV-1 Second-Generation Recombinants (CRF01_AE/CRF07_BC) Identified in Shenzhen, China.
     AIDS Res Hum Retroviruses. 2022 Jan 19. doi: 10.1089/AID.2021.0211.
     PubMed     Abstract available
     
     
     
184. WELLS J, Bai J, Tsementzi D, Jhaney CI, et al
     Exploring the Anal Microbiome in HIV positive and high risk HIV negative Women.
     AIDS Res Hum Retroviruses. 2022 Jan 19. doi: 10.1089/AID.2020.0245.
     PubMed     Abstract available
     
     
     
185. ROBERTS C, Creamer EK, Boone CA, Young AT, et al
     Population Representation in HIV Cure Research: A Review of Diversity within HIV Cure Studies based in the United States.
     AIDS Res Hum Retroviruses. 2022 Jan 12. doi: 10.1089/AID.2021.0127.
     PubMed     Abstract available
     
     
     
186. ABDO M, Wu X, Sharma A, Tassiopoulos K, et al
     Regional Differences in Risk of Recurrent Falls Among Older U.S. Women and Men with HIV in the HIV infection, Aging, and Immune Function Long-Term Observational Study (HAILO).
     AIDS Res Hum Retroviruses. 2022 Jan 12. doi: 10.1089/AID.2021.0162.
     PubMed     Abstract available
     
     
     December 2021
187. MEZOH G, Lutchman N, Worsley C, Gededzha M, et al
     Biomarkers of endothelial dysfunction in Black South African HIV-positive subjects are associated with both high viral load and low CD4 counts.
     AIDS Res Hum Retroviruses. 2021 Dec 30. doi: 10.1089/AID.2021.0052.
     PubMed     Abstract available
     
     
     
188. MAGNASCO L, Pincino R, Pasculli G, Bouba Y, et al
     Predictors of virological failure among people living with HIV switching from an effective first-line antiretroviral regimen.
     AIDS Res Hum Retroviruses. 2021 Dec 30. doi: 10.1089/AID.2021.0016.
     PubMed     Abstract available
     
     
     
189. GONZALEZ GUEMBE M, Tisner Pensado Y, Tejerina Picado F, Diez C, et al
     SARS-COV-2 infection in people living with HIV: experience from a tertiary hospital in Madrid.
     AIDS Res Hum Retroviruses. 2021 Dec 30. doi: 10.1089/AID.2021.0159.
     PubMed     Abstract available
     
     
     
190. TERRY C, Mehta CC, Holloway J, Sheth AN, et al
     Dyspnea and Pulmonary Function Among Participants in the Multicenter AIDS Cohort Study Using Protease Inhibitors: A Cross-Sectional Study.
     AIDS Res Hum Retroviruses. 2021 Dec 30. doi: 10.1089/AID.2021.0082.
     PubMed     Abstract available
     
     
     
191. TURIN CG, Khanjee N, Breaux K, Armamento-Villareal R, et al
     Evaluation of Adherence to Guideline-Based Bone Mineral Density Screening in Veterans with HIV.
     AIDS Res Hum Retroviruses. 2021 Dec 30. doi: 10.1089/AID.2021.0095.
     PubMed     Abstract available
     
     
     
192. SHERRILL-MIX S, Yang M, Aldrovandi GM, Brenchley J, et al
     A summary of the sixth International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment.
     AIDS Res Hum Retroviruses. 2021 Dec 30. doi: 10.1089/AID.2021.0173.
     PubMed     Abstract available
     
     
     
193. HAWLEY I, Song M, Scheckter R, McClure T, et al
     Users' Preferred Characteristics of Vaginal Rings for HIV Prevention: A Qualitative Analysis of Two Phase I Trials.
     AIDS Res Hum Retroviruses. 2021 Dec 30. doi: 10.1089/AID.2021.0077.
     PubMed     Abstract available
     
     
     
194. BONJOCH A, de Cabo F, Puig J, Perez-Alvarez N, et al
     Ultrasound-Based Assessment of Preperitoneal Fat as a Surrogate Marker of Cardiovascular Risk: Comparative Study Between People Living With HIV and Controls.
     AIDS Res Hum Retroviruses. 2021 Dec 30. doi: 10.1089/AID.2021.0141.
     PubMed     Abstract available
     
     
     
195. ASUNDI A, Olson AJ, Jiang W, Varshney SP, et al
     Integrase inhibitor use associated with weight gain in women and incident diabetes mellitus.
     AIDS Res Hum Retroviruses. 2021 Dec 8. doi: 10.1089/AID.2021.0091.
     PubMed     Abstract available
     
     
     
196. SHIKUMA C, Le T, Phuong TV, Chew GM, et al
     Immunologic Change over 72 Weeks following Raltegravir- vs Efavirenz-based Therapy in HIV/HCV co-infected Individuals in Vietnam.
     AIDS Res Hum Retroviruses. 2021 Dec 3. doi: 10.1089/AID.2021.0076.
     PubMed     Abstract available
     
     
     
197. GOODMAN A, Patten L, Castillo-Mancilla JR, Zimmer S, et al
     Factors associated with retention and adherence in a comprehensive, diverse HIV Pre-Exposure Prophylaxis (PrEP) clinic.
     AIDS Res Hum Retroviruses. 2021 Dec 3. doi: 10.1089/AID.2021.0130.
     PubMed     Abstract available
     
     
     
198. PINTO A, Carrera A, Salem H, Thapa K, et al
     Evolution of HIV-1 Surveillance Drug Resistance Mutations Over 10 Years in New South Wales, Australia.
     AIDS Res Hum Retroviruses. 2021;37:897-902.
     PubMed     Abstract available
     
     
     November 2021
199. SABERI P, Campbell C, Lee EY, Guzman J, et al
     Illustrating HIV Cure Research Strategies for the Next Generation of Research Participants: A Research-Community Collaboration.
     AIDS Res Hum Retroviruses. 2021 Nov 15. doi: 10.1089/AID.2021.0149.
     PubMed     Abstract available
     
     
     
200. SUN-SUSLOW N, Balon E, Montoya JL, Saloner R, et al
     Frailty Syndrome is Associated with Poorer Self-Reported Sleep Quality Among Older Persons with Human Immunodeficiency Virus.
     AIDS Res Hum Retroviruses. 2021 Nov 13. doi: 10.1089/AID.2020.0158.
     PubMed     Abstract available
     
     
     
201. JENNINGS L, Kellermann T, Spinelli MA, Nkantsu Z, et al
     Drug resistance, rather than low tenofovir levels in blood or urine, is associated with tenofovir, emtricitabine and efavirenz (TEE) failure in resource-limited settings.
     AIDS Res Hum Retroviruses. 2021 Nov 13. doi: 10.1089/AID.2021.0135.
     PubMed     Abstract available
     
     
     
202. SCHIEFFER RJ, Bryndza Tfaily E, D'Aquila RT, Greene G, et al
     Conjoint Analysis of User Acceptability of Sustained Long-Acting Pre-exposure Prophylaxis (PrEP) for HIV.
     AIDS Res Hum Retroviruses. 2021 Nov 13. doi: 10.1089/AID.2021.0075.
     PubMed     Abstract available
     
     
     October 2021
203. MADYADI A, Dhoro M, Shamu T, Washaya T, et al
     HIV-1 genetic diversity and natural polymorphisms of the integrase gene in integrase inhibitor naive patients in Harare, Zimbabwe.
     AIDS Res Hum Retroviruses. 2021 Oct 29. doi: 10.1089/AID.2021.0084.
     PubMed     Abstract available
     
     
     
204. FURLER RL, Nixon DF
     HIV-1 Exploits Transitions Between CD4+ T Cell Migration and Activation.
     AIDS Res Hum Retroviruses. 2021 Oct 29. doi: 10.1089/AID.2021.0137.
     PubMed     Abstract available
     
     
     
205. BROUILLETTE MJ, Koski L, Scott S, Austin-Keiller A, et al
     Factors influencing psychological distress during the COVID-19 pandemic in people aging with HIV.
     AIDS Res Hum Retroviruses. 2021 Oct 29. doi: 10.1089/AID.2021.0024.
     PubMed     Abstract available
     
     
     
206. HIRANSUTHIKUL A, Chutinet A, Sophonphan J, Ubolyam S, et al
     Incidence and risk factors of ischemic stroke and transient ischemic attack among people living with HIV: a longitudinal cohort study.
     AIDS Res Hum Retroviruses. 2021 Oct 29. doi: 10.1089/AID.2021.0046.
     PubMed     Abstract available
     
     
     
207. WALLNER J, Beck IA, Panpradist N, Ruth PS, et al
     Rapid, Near Point-of-Care Assay for HLA-B*57:01 Genotype Associated with Severe Hypersensitivity Reaction to Abacavir.
     AIDS Res Hum Retroviruses. 2021 Oct 29. doi: 10.1089/AID.2021.0103.
     PubMed     Abstract available
     
     
     
208. LAHER F, Richardson SI, Smith P, Sullivan P, et al
     HIV prevention in a time of COVID-19: A report from the HIVR4P // Virtual conference 2021.
     AIDS Res Hum Retroviruses. 2021 Oct 29. doi: 10.1089/AID.2021.0138.
     PubMed     Abstract available
     
     
     
209. GALAVIZ KI, Shah S, Gutierrez M, Collins LF, et al
     Patient Experiences with Telemedicine for HIV Care during the first COVID-19 Wave in Atlanta, Georgia.
     AIDS Res Hum Retroviruses. 2021 Oct 23. doi: 10.1089/AID.2021.0109.
     PubMed     Abstract available
     
     
     
210. KURLE S, Kandaswami S, Gadhe S, Patil A, et al
     HIV-1 Drug Resistance among treatment naive Transgenders from India.
     AIDS Res Hum Retroviruses. 2021 Oct 15. doi: 10.1089/AID.2021.0157.
     PubMed     Abstract available
     
     
     
211. KUSAGAWA S, Tatsumi M, Sakamoto-Umeki Y, Takekawa N, et al
     Nucleotide sequence of HIV-1-positive specimen reference panel for evaluation of HIV in-vitro diagnostics in Japan.
     AIDS Res Hum Retroviruses. 2021 Oct 15. doi: 10.1089/AID.2021.0160.
     PubMed     Abstract available
     
     
     
212. PEREIRA B, Mazzitelli M, Milinkovic A, Moyle G, et al
     Predictive value of HIV-related versus traditional risk factors for coronary atherosclerosis in people aging with HIV.
     AIDS Res Hum Retroviruses. 2021 Oct 15. doi: 10.1089/AID.2021.0064.
     PubMed     Abstract available
     
     
     
213. KIERI O, Marrone G, Sonnerborg A, Nowak P, et al
     Incidence, treatment and outcome of HIV-associated hematologic malignancies in people living with HIV in Sweden.
     AIDS Res Hum Retroviruses. 2021 Oct 15. doi: 10.1089/AID.2021.0020.
     PubMed     Abstract available
     
     
     
214. SNEDECOR SJ
     Short Communication: Prevalence of Transmitted Resistance to Non-Nucleoside Reverse Transcriptase Inhibitors in European and North American Countries Over 20 Years: An Updated Meta-Analysis.
     AIDS Res Hum Retroviruses. 2021;37:751-753.
     PubMed     Abstract available
     
     
     September 2021
215. JIANG JY, Reid E
     Impact of Insurance Status on Outcomes in Individuals with AIDS-Defining Cancers.
     AIDS Res Hum Retroviruses. 2021 Sep 29. doi: 10.1089/AID.2021.0102.
     PubMed     Abstract available
     
     
     
216. YABAR CA, Vilcarino GF, Espetia S, Lujan F, et al
     Social, epidemiological, and virological characteristics from Peruvian subjects living with HIV-1 / AIDS with different sexual risk behavior.
     AIDS Res Hum Retroviruses. 2021 Sep 25. doi: 10.1089/AID.2021.0067.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.